» Articles » PMID: 37097427

The Role of Smo-Shh/Gli Signaling Activation in the Prevention of Neurological and Ageing Disorders

Overview
Journal Biogerontology
Specialty Geriatrics
Date 2023 Apr 25
PMID 37097427
Authors
Affiliations
Soon will be listed here.
Abstract

Sonic hedgehog (Shh) signaling is an essential central nervous system (CNS) pathway involved during embryonic development and later life stages. Further, it regulates cell division, cellular differentiation, and neuronal integrity. During CNS development, Smo-Shh signaling is significant in the proliferation of neuronal cells such as oligodendrocytes and glial cells. The initiation of the downstream signalling cascade through the 7-transmembrane protein Smoothened (Smo) promotes neuroprotection and restoration during neurological disorders. The dysregulation of Smo-Shh is linked to the proteolytic cleavage of GLI (glioma-associated homolog) into GLI3 (repressor), which suppresses target gene expression, leading to the disruption of cell growth processes. Smo-Shh aberrant signalling is responsible for several neurological complications contributing to physiological alterations like increased oxidative stress, neuronal excitotoxicity, neuroinflammation, and apoptosis. Moreover, activating Shh receptors in the brain promotes axonal elongation and increases neurotransmitters released from presynaptic terminals, thereby exerting neurogenesis, anti-oxidation, anti-inflammatory, and autophagy responses. Smo-Shh activators have been shown in preclinical and clinical studies to help prevent various neurodegenerative and neuropsychiatric disorders. Redox signalling has been found to play a critical role in regulating the activity of the Smo-Shh pathway and influencing downstream signalling events. In the current study ROS, a signalling molecule, was also essential in modulating the SMO-SHH gli signaling pathway in neurodegeneration. As a result of this investigation, dysregulation of the pathway contributes to the pathogenesis of various neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).Thus, Smo-Shh signalling activators could be a potential therapeutic intervention to treat neurocomplications of brain disorders.

Citing Articles

Identification of Key Genes in Esketamine's Therapeutic Effects on Perioperative Neurocognitive Disorders via Transcriptome Sequencing.

Hu W, Luo J, Li H, Luo Y, Zhang X, Wu Z Drug Des Devel Ther. 2025; 19:981-1000.

PMID: 39974608 PMC: 11836629. DOI: 10.2147/DDDT.S510752.


Assessment of the level of apoptosis in differentiated pseudo-neuronal cells derived from neural stem cells under the influence of various inducers.

Naghshbandieh A, Naghshbandieh A, Barfi E, Abkhooie L Am J Stem Cells. 2025; 13(6):250-270.

PMID: 39850017 PMC: 11751472. DOI: 10.62347/BPTG6174.


Primary cilia in Parkinson's disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons.

Tian Z, Zhang Y, Xu J, Yang Q, Hu D, Feng J Front Aging Neurosci. 2024; 16:1451655.

PMID: 39364348 PMC: 11447156. DOI: 10.3389/fnagi.2024.1451655.


Transcriptional Patterns in Stages of Alzheimer's Disease Are Cell-Type-Specific and Partially Converge with the Effects of Alcohol Use Disorder in Humans.

Joshi A, Giorgi F, Sanna P eNeuro. 2024; 11(10).

PMID: 39299805 PMC: 11485264. DOI: 10.1523/ENEURO.0118-24.2024.


Study of the Immune Infiltration and Sonic Hedgehog Expression Mechanism in Synovial Tissue of Rheumatoid Arthritis-Related Interstitial Lung Disease under Machine Learning CIBERSORT Algorithm.

Lu Q, Jiang Y, Cang X, Pan J, Shen X, Tang R Mol Biotechnol. 2024; .

PMID: 39110383 DOI: 10.1007/s12033-024-01245-z.


References
1.
Abdul-Muneer P, Chandra N, Haorah J . Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol. 2014; 51(3):966-79. PMC: 9420084. DOI: 10.1007/s12035-014-8752-3. View

2.
Aberger F, Kern D, Greil R, Hartmann T . Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies. Vitam Horm. 2012; 88:25-54. DOI: 10.1016/B978-0-12-394622-5.00002-X. View

3.
Adams J, Doyle D, Graham D, Lawrence A, McLellan D, Gennarelli T . The contusion index: a reappraisal in human and experimental non-missile head injury. Neuropathol Appl Neurobiol. 1985; 11(4):299-308. DOI: 10.1111/j.1365-2990.1985.tb00027.x. View

4.
Al-Ayadhi L . Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochem Res. 2011; 37(2):394-400. PMC: 3264868. DOI: 10.1007/s11064-011-0624-x. View

5.
Alenina N, Bashammakh S, Bader M . Specification and differentiation of serotonergic neurons. Stem Cell Rev. 2006; 2(1):5-10. DOI: 10.1007/s12015-006-0002-2. View